Inventor
NESBURN ANTHONY B
US15 patents
⚠️ This page may combine multiple inventors who share the name “NESBURN ANTHONY B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CEDARS SINAI MEDICAL CENTER
9 patentsUS5955088ASep 21, 1999
Pharmaceutical compsition of herpes simplex virus type-1 (HSV-1), glycoproteins
CEDARS SINAI MEDICAL CENTER96 citations95
US5431790AJul 11, 1995
Method of crosslinking amino acid containing polymers using photoactivatable chemical crosslinkers
CEDARS SINAI MEDICAL CENTER42 citations94
US5024742AJun 18, 1991
Method of crosslinking amino acid containing polymers using photoactivatable chemical crosslinkers
CEDARS SINAI MEDICAL CENTER100 citations94
US5660692AAug 26, 1997
Method of crosslinking amino acid-containing polymers using photoactivatable chemical crosslinkers
CEDARS SINAI MEDICAL CENTER83 citations93
US6774119B1Aug 10, 2004
Herpes simplex virus type 1 (hsv-1)-derived vector for selectively inhibiting malignant cells and methods for its use to treat cancers and to express desired traits in malignant and non-malignant mammalian cells
CEDARS SINAI MEDICAL CENTER21 citations91
US5632992AMay 27, 1997
Process for the expression of herpes simplex virus type 1 glycoprotein E and method of use
CEDARS SINAI MEDICAL CENTER21 citations90
US5294314AMar 15, 1994
Method of crosslinking amino acid containing polymers using photoactivatable chemical crosslinkers
CEDARS SINAI MEDICAL CENTER31 citations90
US6193984B1Feb 27, 2001
Pharmaceutical composition of herpes simplex virus typ-1 (HSV-1) glycoproteins
CEDARS SINAI MEDICAL CENTER36 citations89
US6838279B2Jan 4, 2005
Herpes simplex virus type 1 (HSV-1)-derived vector for selectively inhibiting malignant cells and for expressing desired traits in malignant and non-malignant mammalian cells
CEDARS SINAI MEDICAL CENTER10 citations72
ISTA PHARMACEUTICALS INC
3 patentsUS6551590B2Apr 22, 2003
Hyaluronidase preparation for ophthalmic administration and enzymatic methods for accelerating clearance of hemorrhagic blood from the vireous body of the eye
ISTA PHARMACEUTICALS INC40 citations94
US6610292B2Aug 26, 2003
Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
ISTA PHARMACEUTICALS INC54 citations92
US6939542B2Sep 6, 2005
Hyaluronidase preparation for ophthalmic administration and enzymatic methods for accelerating clearance of hemorrhagic blood from the vitreous body of the eye
ISTA PHARMACEUTICALS INC12 citations90
ADVANCED CORNEAL SYSTEMS
2 patentsUS6039943AMar 21, 2000
Method for accelerating clearance of hemorrhagic blood from the vitreous body with hyaluronidase
ADVANCED CORNEAL SYSTEMS33 citations93
US6863886B2Mar 8, 2005
Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
ADVANCED CORNEAL SYSTEMS29 citations87